Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings and focused instead on the disappointing gross margin. Here’s how the company did, compared to analysts’ consensus estimates from LSEG: Earnings per share: 11 cents vs. 10 cents expected Revenue: $481 million vs. $470 million expected … Read more
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023. Kelly Sullivan | Getty Images Entertainment | Getty Images 23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities … Read more
Shares of Hims & Hers Health closed down around 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved. Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called … Read more
Innovaccer CEO Abhinav Shashank. Courtesy: Innovaccer As doctors and nurses face historic rates of burnout, Innovacer says artificial intelligence is here to help. The health-care data company on Monday announced a suite of AI agents that are designed to automate repetitive, “low-value” tasks for clinicians. “We just don’t have enough capacity in the health system to … Read more